2 The histopathology of chronic myeloproliferative diseases
References (99)
- et al.
Detection of chromosome 20q-deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes
Blood
(1996) - et al.
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia
Blood
(1998) - et al.
BCR-ABL transcripts in bone marrow aspirates of Ph-negative essential thrombocythemia patients: Clinical presentation
Blood
(1997) - et al.
Myelofibrosis in chronic myeloproliferative disorders: Incidence among subtypes according to the Hannover classification
Pathology, Research and Practice
(1993) - et al.
Remission of chronic idiopathic myelofibrosis by busulfan treatment
American Journal of the Medical Science
(1988) - et al.
Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia
Blood
(1998) - et al.
Morphometric study of the bone marrow in polycythemia vera following interferon-alpha therapy
Pathology, Research and Practice
(1993) - et al.
Chronic myeloproliferative disorders in bone marrow biopsies
Pathology Research and Practice
(1990) - et al.
Long-term interferon therapy for thrombocytosis in myeloproliferative diseases
Lancet
(1989) - et al.
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea
Blood
(1993)
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia
Blood
(1994)
Separation of human megakaryocytes by state of differentiation on continuous gradients of Percoll: Size and ploidy analysis of cells identified by monoclonal antibody to glycoprotein IIb/IIIa
Blood
(1986)
Clonal granulocytes and bone marrow cells in the cellular phase of Agnogenic myeloid metaplasia
Blood
(1991)
Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course
Blood
(1990)
Increased thromboxane biosynthesis in patients with polycythemia vera: Evidence for aspirin-suppressible platelet activation in vivo
Blood
(1992)
Might essential thrombocythemia carry Ph anomaly? Letter to Editor
Blood
(1998)
Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia
Blood
(1991)
Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders—Analysis of planimetric and numeric characteristics by means of a knowledge based system
Experimental Pathology
(1990)
The effect of α-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia
Blood
(1991)
Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B-cells
Blood
(1994)
Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD)
European Journal of Haematology
(1993)
Randomized study on hydroxyurea alone versus hydroxyurea combined with low dose interferon α 2b for chronic myeloid leukemia
Blood
(1998)
The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical myeloid, and chronic myelomonocytic leukaemia
British Journal of Haematology
(1994)
A new histological embedding method by low-temperature polymerisation of methyl methacrylate allowing immuno- and enzyme histochemical studies on semi-thin sections of undecalcified bone marrow biopsies
Histochemistry
(1992)
Successful retreatment of an anti-interferon resistant polycythemia vera patient with lymphoblastoid interferon-alpha N1 and in vitro studies on the specificity of the antibodies
British Journal of Haematology
(1994)
Atlas of Tumor Pathology: Tumors of the Bone Marrow
(1994)
Numerical increase of pseudo-Gaucher cells in CML-indication of a more advanced stage of disease
Blood
(1995)
Square sampling. An easy method of estimating numerical density of cells or particles within a tissue
Analytical and Quantitative Cytology and Histology
(1997)
Frequency of pseudo-Gaucher cells within diagnostic bone marrow biopsies from patients with a Ph-positive CML
Virchows Archive A
(1997)
The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia
Virchows Archive A
(1992)
Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts
Annals of Hematology
(1992)
Prognostic evaluation of initial bone marrow histopathological features in chronic granulocytic leukemia
Acta Haematologica
(1989)
Interferon-alpha induced morphological changes of megakaryocytes: a histomorphometrical study on bone marrow biopsies in chronic myeloproliferative disorders with excessive thrombocytosis
British Journal of Haematology
(1990)
Hydroxyurea in the treatment of patients with essential thrombocythemia to high risk of thrombosis: a prospective randomized trial
New England Journal of Medicine
(1995)
Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes
American Journal of Clinical Pathology
(1993)
Hematopathologic findings in the myeloproliferative disorders
Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and secondary hematologic malignancies
Immunohistochemical evaluations of bone marrow lymphoid nodules in chronic myeloproliferative disorders
Virchows Archiv A
(1991)
From efficacy to safety: A Polycythemia Vera Study Group report on hydroxyurea in patients with polycythemia vera
Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia
Leukemia and Lymphoma
(1992)
Chronic megakaryocytic granulocytic myelosis—CMGM. A subtype of chronic myeloid leukemia
Virchows Archive A
(1980)
Hannover classification of chronic myeloproliferative diseases by histopathology of the bone marrow
Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies
Leukemia and Lymphoma
(1996)
Histological classification and grading of bone marrow biopsies provides prognostic data at diagnosis in patients with chronic myeloproliferation
Hematologica
(1998)
Evaluation of thrombopoiesis in essential thrombocythaemia before and after α-interferon treatment
Thrombosis and Haemostasis
(1987)
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
New England Journal of Medicine
(1998)
Editorial: A change of cure for every patient with chronic myeloid leukemia
New England Journal of Medicine
(1998)
Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities
Virchows Archive A
(1991)
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia
Cancer
(1986)
Cited by (92)
SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis
2024, Clinical Lymphoma, Myeloma and LeukemiaMyeloproliferative neoplasms
2019, Rodak’s Hematology: Clinical Principles and ApplicationsCan the Use of Bone Marrow Parameters Improve the Efficacy of Risk Prediction Scores in Chronic Myeloid Leukemia in Imatinib Era?
2017, Clinical Lymphoma, Myeloma and LeukemiaCitation Excerpt :Thus, the baseline phase remains the most important prognostic factor determining patient outcome. If untreated, CML-CP will progress to the CML-AP or CML-BP within the next 1 to 2 years.10 This risk has become rare, but has not been completely avoided using current TKI therapy; ≤ 20% to 40% of CML-CP cases will eventually develop imatinib resistance or intolerance and require a change of therapy.11
Chronic myelogenous leukemia
2011, Blood and Bone Marrow Pathology: Expert ConsultEssential thrombocythemia and primary myelofibrosis
2011, Blood and Bone Marrow Pathology: Expert Consult
Copyright © 1998 Published by Elsevier Ltd.